Resultados da busca - Filip Bergquist

Wearable sensor measurements in relation to clinical characteristics and mortality in patients with Parkinson’s disease por Daniel von Below, Susanna M. Wallerstedt, Filip Bergquist

Obter o texto integral

Effects of rotigotine on sleep in Parkinson’s disease patients: a Parkinson’s KinetiGraph study por Sotirios Grigoriou, Sotirios Grigoriou, Carin Janz, Carin Janz, Malcolm Horne, Filip Bergquist, Filip Bergquist, Nil Dizdar, Per Odin, Per Odin

Obter o texto integral

Life with Parkinson’s Disease During the COVID-19 Pandemic: The Pressure Is “OFF” por Trine HØrmann Thomsen, Susanna M. Wallerstedt, Kristian Winge, Filip Bergquist

Obter o texto integral

Local Change in Urinary Bladder Contractility Following CNS Dopamine Denervation in the 6-OHDA Rat Model of Parkinson’s Disease por Reinika Mitra, Patrik Aronsson, Michael Winder, Gunnar Tobin, Filip Bergquist, Thomas Carlsson

Obter o texto integral

Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson’s disease por Per Odin, K. Ray Chaudhuri, Jens Volkmann, Angelo Antonini, Alexander Storch, Espen Dietrichs, Zvezdan Pirtošek, Tove Henriksen, Malcolm Horne, David Devos, Filip Bergquist

Obter o texto integral

Real-World Safety and Effectiveness of 24-Hour Foslevodopa/Foscarbidopa in Parkinson's Disease: ROSSINI Study 6-Month Interim Results por Wolfgang H. Jost, Filip Bergquist, Andrew Evans, Sharon Hassin-Baer, Robert A. Hauser, Tove Henriksen, Irene A. Malaty, Tiago A. Mestre, Pablo Mir, Ramon Rodriguez, Petra Schwingenschuh, Mihaela Simu, Lars Bergmann, Teresa T. Zhou, Sarah Caughlin, Mallika Gopalkrishnan, Pavnit Kukreja, Marie O’Meara, Juan Carlos Parra, Megha B. Shah, Jason Aldred

Obter o texto integral

Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study por Jason Aldred, Eric Freire-Alvarez, Alexander V. Amelin, Angelo Antonini, Bruno Bergmans, Filip Bergquist, Manon Bouchard, Kumar Budur, Camille Carroll, K. Ray Chaudhuri, Susan R. Criswell, Erik H. Danielsen, Florin Gandor, Jia Jia, Thomas E. Kimber, Hideki Mochizuki, Weining Z. Robieson, Amy M. Spiegel, David G. Standaert, Saritha Talapala, Maurizio F. Facheris, Victor S. C. Fung

Obter o texto integral

Continuous subcutaneous foslevodopa/foscarbidopa infusion for the treatment of motor fluctuations in Parkinson’s disease: Considerations for initiation and maintenance por Victor S.C. Fung, Jason Aldred, Martha P. Arroyo, Filip Bergquist, Agnita J.W. Boon, Manon Bouchard, Sarah Bray, Sara Dhanani, Maurizio F. Facheris, Nahome Fisseha, Eric Freire-Alvarez, Robert A. Hauser, Anna Jeong, Jia Jia, Pavnit Kukreja, Michael J. Soileau, Amy M. Spiegel, Saritha Talapala, Arjun Tarakad, Enrique Urrea-Mendoza, Jorge Zamudio, Rajesh Pahwa

Obter o texto integral

Correction: Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study por Jason Aldred, Eric Freire-Alvarez, Alexander V. Amelin, Angelo Antonini, Bruno Bergmans, Filip Bergquist, Manon Bouchard, Kumar Budur, Camille Carroll, K. Ray Chaudhuri, Susan R. Criswell, Erik H. Danielsen, Florin Gandor, Jia Jia, Thomas E. Kimber, Hideki Mochizuki, Weining Z. Robieson, Amy M. Spiegel, David G. Standaert, Saritha Talapala, Maurizio F. Facheris, Victor S. C. Fung

Obter o texto integral